Literature DB >> 758904

The metabolism of tamoxifen in human.

H K Adam, E J Douglas, J V Kemp.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 758904     DOI: 10.1016/0006-2952(79)90283-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  13 in total

Review 1.  Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors:  P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

Review 2.  Long-term adjuvant tamoxifen therapy for breast cancer.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1990-05       Impact factor: 4.872

Review 3.  Clinical epidemiology and pharmacology of CYP2D6 inhibition related to breast cancer outcomes.

Authors:  Deirdre P Cronin-Fenton; Timothy L Lash
Journal:  Expert Rev Clin Pharmacol       Date:  2011-05       Impact factor: 5.045

4.  The development of tamoxifen for breast cancer therapy: a tribute to the late Arthur L. Walpole.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1988-07       Impact factor: 4.872

Review 5.  Metabolism and transport of tamoxifen in relation to its effectiveness: new perspectives on an ongoing controversy.

Authors:  Deirdre P Cronin-Fenton; Per Damkier; Timothy L Lash
Journal:  Future Oncol       Date:  2014-01       Impact factor: 3.404

Review 6.  New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.

Authors:  V Craig Jordan
Journal:  Steroids       Date:  2007-07-27       Impact factor: 2.668

7.  Evidence for the metabolic activation of non-steroidal antioestrogens: a study of structure-activity relationships.

Authors:  K E Allen; E R Clark; V C Jordan
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

8.  Clinical pharmacology of tamoxifen and N-desmethyltamoxifen in patients with advanced breast cancer.

Authors:  P Wilkinson; G Ribeiro; H Adam; J Patterson
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

9.  High affinity binding of anti-oestrogen to the chick liver nuclear oestrogen receptor.

Authors:  C B Lazier; V C Jordan
Journal:  Biochem J       Date:  1982-08-15       Impact factor: 3.857

Review 10.  Metabolites of tamoxifen in animals and man: identification, pharmacology, and significance.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.